Evaluation of clinical and socio-demographic risk factors for antibacterial resistance of Helicobacter pylori in Bulgaria

Journal of Medical Microbiology

Volumn 58, Issue 1, 2009, Pages 94-100

  Boyanova, Lyudmila ^a   Ilieva, Juliana ^a   Gergova, Galina ^a   Spassova, Zoya ^b   Nikolov, Rossen ^b   Davidkov, Lubomir ^c   Evstatiev, Ivailo ^c   Kamburov, Victor ^d   Katsarov, Nikolai ^c   Mitov, Ivan ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY HOSPITAL ST IVAN RILSKI   (Bulgaria)

^c UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^d Pirogov Emergency Hospital   (Bulgaria)

Author keywords

95 CI; 95 confidence interval; Area under the curve; AUC; Non steroidal anti inflammatory drug; NSAID; Odds ratio; OR; Receiver operating characteristic; ROC

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; TETRACYCLINE;

ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BIRTHPLACE; BULGARIA; CHRONIC GASTRITIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE DURATION; DUODENUM ULCER; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIATUS HERNIA; HOSPITAL; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SEX RATIO; STATISTICAL SIGNIFICANCE; STOMACH ULCER; SYMPTOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BULGARIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 58149508318     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.003855-0     Document Type: Article

References (33)

1. Boyanova, L. (2007). Detection of Helicobacter pylori infection in symptomatic Bulgarian adults. Clin Microbiol Infect 13, 908-914.
2. Boyanova, L., Gergova, G., Nikolov, R., Davidkov, L., Kamburov, V., Jelev, C. & Mitov, I. (2008). Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods. Diagn Microbiol Infect Dis 60, 409-415.
3. Broutet, N., Tchamgoue, S., Pereira, E., Lamouliatte, H., Salamon, R. & Mégraud, F. (2003). Risk factors for failure of Helicobacter pylori therapy-results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther 17, 99-109.
4. Buzas, G. M., Lotz, G. & Kiss, A. (2007). The epidemiology of clarithromycin resistance of Helicobacter pylori infection in Hungary. Orv Hetil 148, 1461-1467.
5. Chisholm, S. A., Teare, E. L., Davies, K. & Owen, R. J. (2007). Surveillance of primary antibiotic resistance of Helicobacter pylori at centres in England and Wales over a six-year period (2000-2005). Euro Surveill 12, E3-E4.
6. CLSI (2000). Performance Standards for Antimicrobial Susceptibility Testing, tenth informational supplement, approved standard M100-S10, M7. Wayne, PA: Clinical and Laboratory Standards Institute (formerly known as the National Committee for Clinical Laboratory Standards).
7. Duck, W. M., Sobel, J., Pruckler, J. M., Song, Q., Swerdlow, D., Friedman, C., Sulka, A., Swaminathan, B., Taylor, T. & other authors (2004). Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg Infect Dis 10, 1088-1094.
8. Elviss, N. C., Owen, R. J., Xerry, J., Walker, A. M. & Davies, K. (2004). Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales. J Antimicrob Chemother 54, 435-440.
9. Elviss, N. C., Owen, R. J., Breathnach, A., Palmer, C. & Shetty, N. (2005). Helicobacter pylori antibiotic-resistance patterns and risk factors in adult dyspeptic patients from ethnically diverse populations in central and south London during 2000. J Med Microbiol 54, 567-574.
10. Ferrero, M., Ducons, J. A., Sicilia, B., Santolaria, S., Sierra, E. & Gomollon, F. (2000). Factors affecting the variation in antibiotic resistance of Helicobacter pylori over a 3-year period. Int J Antimicrob Agents 16, 245-248.
11. Gisbert, J. P., Marcos, S., Gisbert, J. L. & Pajares, J. M. (2001). Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia. Eur J Gastroenterol Hepatol 13, 1303-1307.
12. Halitim, F., Vincent, P., Michaud, L., Kalach, N., Guimber, D., Boman, F., Turck, D. & Gottrand, F. (2006). High rate of Helicobacter pylori reinfection in children and adolescents. Helicobacter 11, 168-172.
13. Huang, J. Q., Zheng, G. F., Hunt, R. H., Wong, W. M., Lam, S. K., Karlberg, J. & Wong, B. C. (2005). Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review. World J Gastroenterol 11, 2726-2732.
14. Katelaris, P. H., Nguyen, T. V., Robertson, G. J., Bradbury, R. & Ngu, M. C. (1998). Prevalence and demographic determinants of metronidazole resistance by Helicobacter pylori in a large cosmopolitan cohort of Australian dyspeptic patients. Aust N Z J Med 28, 633-638.
15. Kato, M., Yamaoka, Y., Kim, J. J., Reddy, R., Asaka, M., Kashima, K., Osato, M. S., El-Zaatari, F. A., Graham, D. Y. & Kwon, D. H. (2000). Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother 44, 2214-2216.
16. Kawabata, H., Habu, Y., Tomioka, H., Kutsumi, H., Kobayashi, M., Oyasu, K., Hayakumo, T., Mizuno, S., Kiyota, K. & other authors (2003). Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin. Aliment Pharmacol Ther 17, 259-264.
17. Koivisto, T. T., Rautelin, H. I., Voutilainen, M. E., Niemelä, S. E., Heikkinen, M., Sipponen, P. I. & Färkkilä, M. A. (2004). Primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Finnish population. Aliment Pharmacol Ther 19, 1009-1017.
18. Lui, S. Y., Yeoh, K. G. & Ho, B. (2003). Metronidazole- resistant Helicobacter pylori is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian population. J Clin Microbiol 41, 5011-5014.
19. McMahon, B. J., Hennessy, T. W., Bensler, J. M., Bruden, D. L., Parkinson, A. J., Morris, J. M., Reasonover, A. L., Hurlburt, D. A., Bruce, M. G. & other authors (2003). The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections. Ann Intern Med 139, 463-469.
20. Megraud, F. (2004). H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53, 1374-1384.
21. Megraud, F. & Lehours, P. (2007). Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 20, 280-322.
22. Megraud, F., Lehn, N., Lind, T., Bayerdorffer, E., O'Morain, C., Spiller, R., Unge, P., van Zanten, S. V., Wrangstadh, M. & Burman, C. F. (1999). Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother 43, 2747-2752.
23. Meyer, J. M., Silliman, N. P., Wang, W., Siepman, N. Y., Sugg, J. E., Morris, D., Zhang, J., Bhattacharyya, H., King, E. C. & Hopkins, R. J. (2002). Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999. Ann Intern Med 136, 13-24.
24. Ojetti, V., Migneco, A., Silveri, N. G., Ghirlanda, G., Gasbarrini, G. & Gasbarrini, A. (2005). The role of H. pylori infection in diabetes. Curr Diabetes Rev 1, 343-347.
25. Osato, M. S., Reddy, R., Reddy, S. G., Penland, R. L., Malaty, H. M. & Graham, D. Y. (2001). Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med 161, 1217-1220.
26. Parsons, H. K., Carter, M. J., Sanders, D. S., Winstanley, T. & Lobo, A. J. (2001). Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status. Aliment Pharmacol Ther 15, 1473-1478.
27. Pilotto, A., Rassu, M., Leandro, G., Franceschi, M., Di Mario, F. & Interdisciplinary Group for the Study of Ulcer (2000). Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. Dig Liver Dis 32, 763-768.
28. Sargýn, M., Uygur-Bayramicli, O., Sargýn, H., Orbay, E., Yavuzer, D. & Yayla, A. (2003). Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori. World J Gastroenterol 9, 1126-1128.
29. Seow, J. & Chew, F. T. (2004). Risk factors for Helicobacter pylori resistance. Ann Intern Med 140, 931.
30. Thyagarajan, S. P., Ray, P., Das, B. K., Ayyagari, A., Khan, A. A., Dharmalingam, S., Rao, U. A., Rajasambandam, P., Ramathilagam, B. & other authors (2003). Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: multicentric study. J Gastroenterol Hepatol 18, 1373-1378.
31. Toracchio, S. & Marzio, L. (2003). Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002. Dig Liver Dis 35, 541-545.
32. Van Doorn, L. J., Schneeberger, P. M., Nouhan, N., Plaisier, A. P., Quint, W. G. & de Boer, W. A. (2000). Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment. Gut 46, 321-326.
33. Wang, W. H., Wong, W. M., Dailidiene, D., Berg, D. E., Gu, Q., Lai, K. C., Lam, S. K. & Wong, B. C. (2003). Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents. Gut 52, 490-495.